# PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores

> **NCT03495427** · PHASE2,PHASE3 · RECRUITING · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 60 (estimated)

## Conditions studied

- Prostate Cancer
- Recurrent Prostate Cancer

## Interventions

- **DRUG:** F-DCFPyL Injection
- **DIAGNOSTIC_TEST:** PSMA PET

## Key facts

- **NCT ID:** NCT03495427
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-12-18
- **Primary completion:** 2029-02
- **Final completion:** 2029-05
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-03-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03495427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03495427, "PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03495427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*